Draft:Dr. H Antaki: Difference between revisions

This is a draft Articles for creation (AfC) submission. It is not currently pending review. While there are no deadlines, abandoned drafts may be deleted after six months. To edit the draft click on the “Edit” tab at the top of the window. To be accepted, a draft should: It is strongly discouraged to write about yourself, your business or employer. If you do so, you must declare it. Where to get help If you need help editing or submitting your draft, please ask us a question at the AfC Help Desk or get live help from experienced editors. These venues are only for help with editing and the submission process, not to get reviews. If you need feedback on your draft, or if the review is taking a lot of time, you can try asking for help on the talk page of a relevant WikiProject. Some WikiProjects are more active than others so a speedy reply is not guaranteed. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags.

Egyptian organic chemist

Hekmat Bashir Antaki (11 April 1923 – 31 December 1992) was an Egyptian organic chemist known for his pioneering work on ultraviolet absorption in heterocyclic compounds and for synthesizing novel quinoline, indenoquinoline, and glycosylbenziminazole derivatives. His research, published in Royal Society of Chemistry journals between 1951 and 1967, contributed to the chemical foundations of several anti-malarial and anti-cancer agents. Antaki earned his PhD in organic chemistry from Queen Mary University of London and later served as President of the Institute of Tropical Disease in Cairo.

Antaki was born in Cairo, Egypt, on 11 April 1923. He pursued higher education in chemistry and was awarded a scholarship to study in the United Kingdom. He earned his Ph.D. in Organic Chemistry at Queen Mary University of London, where he conducted research in heterocyclic chemistry under the Royal Society of Chemistry journals. His academic training formed the basis for his later medicinal and synthetic chemistry contributions.

After completing his studies in London, Antaki returned to Egypt, where he became President of the Institute of Tropical Disease in Cairo. His scientific career focused on the structure and reactivity of heterocyclic compounds and their applications in medicine. Antaki published several influential papers between the early 1950s and late 1960s in leading journals of the Royal Society of Chemistry. His research explored synthetic routes to new heterocycles and investigated their ultraviolet absorption spectra as a means to characterize molecular structures.

Antaki’s research spanned several key areas of organic and medicinal chemistry:

• **Ultraviolet absorption in organic chemistry**: He was among the early researchers to apply UV spectroscopy to heterocyclic compounds, producing reference data that became useful for structural identification in organic chemistry.
• **Synthesis of heterocyclic compounds**: Antaki developed new synthetic pathways for quinoline, indenoquinoline, and glycosylbenziminazole derivatives.
• **Medicinal relevance**: His methods influenced the development of anti-malarial drugs based on quinoline scaffolds, as well as anticancer agents derived from indenoquinoline structures.

Antaki’s work has had a lasting impact on modern medicinal chemistry:

• **Anti-malarial drug development**: His synthetic routes for quinoline derivatives expanded chemical understanding of compounds central to drugs such as chloroquine, enabling improved pharmacological properties.
• **Anti-cancer agents**: Indenoquinoline derivatives first synthesized in his laboratory later served as scaffolds for anticancer compounds.
• **Analytical chemistry**: His application of UV absorption spectroscopy to heterocycles provided a rapid and reliable method for molecular characterization, a technique still in use in drug discovery pipelines.
• **Glycosylated heterocycles**: Antaki’s research on glycosylbenziminazoles contributed to the chemical basis of glycosylated drugs, relevant in antiviral and enzyme inhibitor therapies.

• Antaki, H.; Petrow, V. (1951). “New Syntheses of Heterocyclic Compounds. Part XII. The Condensation of Ethyl p-Aminocrotonate with Some Cyclic Amidines”. Journal of the Chemical Society (Resumed). pp. 551–555. ^[1]

• Antaki, H.; Petrow, V. (1951). “Steroids and Related Compounds. Part XII. Some Heterocyclic Derivatives”. Journal of the Chemical Society (Resumed). pp. 901–903. ^[2]

• Antaki, H.; Petrow, V. (1951). “Some Glycosylbenziminazoles”. Journal of the Chemical Society (Resumed). pp. 2873–2877. ^[3]

• Antaki, H. (1963). “The Synthesis of Ethyl 4-Aryl-5,6,7,8-tetrahydro-5-oxo-quinoline-3-carboxylates and their Derivatives”. Journal of the Chemical Society (Resumed). pp. 4877–4880. ^[4]

• Antaki, H. (1967). “Synthetic Routes to Benz- and Naphth-indenoquinolines”. Journal of the Chemical Society C: Organic. pp. 1581–1584. ^[5]